title: Peroxisome proliferator-activated receptor δ agonist, HPP593, prevents renal necrosis under chronic ischemia.
abstract: The Goldblatt's 2 kidney 1 clip (2K1C) rat animal model of renovascular hypertension is characterized by ischemic nephropathy of the clipped kidney. 2K1C rats were treated with a specific peroxisome proliferator-activated receptor δ (PPARδ) agonist, HPP593. Clipped kidneys from untreated rats developed tubular and glomerular necrosis and massive interstitial, periglomerular and perivascular fibrosis. HPP593 kidneys did not exhibit any histochemical features of necrosis; fibrotic lesions were present only in perivascular areas. Necrosis in the untreated clipped kidneys was associated with an increased oxidative stress, up regulation and mitochondrial translocation of the pro-death protein BNIP3 specifically in tubules. In the kidneys of HPP593-treated rats oxidative stress was attenuated and BNIP3 protein decreased notably in the mitochondrial fraction when compared to untreated animals. In untreated clipped kidneys, mitochondria were dysfunctional as revealed by perturbations in the levels of MCAD, COXIV, TFAM, and Parkin proteins and AMPK activation, while in HPP593-treated rats these proteins remained at the physiological levels. Nuclear amounts of oxidative stress-responsive proteins, NRF1 and NRF2 were below physiological levels in treated kidneys. Mitochondrial biogenesis and autophagy were inhibited similarly in both treated and untreated 2K1C kidneys as indicated by a decrease in PGC1-α and deficiency of the autophagy-essential proteins LC3-II and ATG5. However, HPP593 treatment resulted in increased accumulation of p62 protein, an autophagic substrate and an enhancer of NRF2 activity. Therefore, inhibition of BNIP3 activation by the preservation of mitochondrial function and control of oxidative stress by PPARδ is the most likely mechanism to account for the prevention of necrotic death in the kidney under conditions of persistent ischemia.
authors.affiliation: Department of Medicine, The University of Toledo School of Medicine, Toledo, Ohio, United States of America. Larisa.fedorova@utoledo.edu
authors.forename: Larisa V
authors.initials: LV
authors.lastname: Fedorova
authors.forename: Komal
authors.initials: K
authors.lastname: Sodhi
authors.forename: Cara
authors.initials: C
authors.lastname: Gatto-Weis
authors.forename: Nitin
authors.initials: N
authors.lastname: Puri
authors.forename: Terry D
authors.initials: TD
authors.lastname: Hinds
authors.forename: Joseph I
authors.initials: JI
authors.lastname: Shapiro
authors.forename: Deepak
authors.initials: D
authors.lastname: Malhotra
mesh_terms: D000818:Animals; D001483:Base Sequence; D002908:Chronic Disease; D017931:DNA Primers; D007511:Ischemia / Q000473:pathology*; D007668:Kidney / Q000098:blood supply*; D008297:Male; D009336:Necrosis / Q000517:prevention & control*; D047494:PPAR delta / Q000819:agonists*; D051381:Rats; D017207:Rats, Sprague-Dawley
chemical_list: D017931:DNA Primers; D047494:PPAR delta